PRESTRELSKI STEVEN - Insider Non-Derivative Transactions at Xeris Biopharma Holdings, Inc. (XERS) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 31, 2023, PRESTRELSKI STEVEN's relationship to Xeris Biopharma Holdings, Inc. (XERS) is Officer (Chief Scientific Officer), and currently has 719,780 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other XERS insiders.

Data Source: SEC.
PRESTRELSKI STEVEN - Insider Non-Derivative Transactions of XERS Common Stock
PRESTRELSKI STEVEN - Insider Non-Derivative Transactions at XERS
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 1, 2023 Acquisition -- (Common Stock) 150000 0 719780